|
|
|
|
FDA seeks more data on MannKind's inhaled insulin
ET BOSTON (Reuters) U.S.regulators have requested more information on an inhaled insulin device being developed by MannKind Corp, sending the company's shares down 24.7 percent. MannKind said on Monday that it had received a so-called complete response...
|
|
|
FDA seeks more data on MannKind's inhaled insulin
BOSTON (Reuters) - U.S.regulators have requested more information on an inhaled insulin device being developed by MannKind Corp, sending the company's shares down 24.7 percent. MannKind said on Monday that it had received a so-called complete response...
|
|
|
UPDATE 4-FDA seeks more data on MannKind's inhaled insulin
BOSTON, March 15 (Reuters) - U.S.regulators have requested more information on an inhaled insulin device being developed by MannKind Corp, sending the company's shares down 24.7 percent. MannKind said on Monday that it had received a so-called complete...
|
|
|
FDA requires more details on MannKind's Afrezza
* FDA requests available data on Afrezza clinical utility * Requests comparability information on commercial version * Requests updated safety data; cites no safety concerns * Shares fall 9.5 pct in mid-morning trading BOSTON, March 15 - U.S.regulators have...
|
|
|
UPDATE 2-FDA requires more details on MannKind's Afrezza
By Toni Clarke BOSTON, March 15 (Reuters) - U.S.regulators have requested more information on an inhaled insulin device being developed by MannKind Corp, the company said on Monday, sending its shares down nearly 10 percent in mid-morning trading. Valencia...
|
|
|
Eli Lilly and Company: Findings in eli lilly and company reported from Eli Lilly and Company
Today's Medical & Research News Findings in reported from March 11th, 2010 Printer-Friendly Version City:Indianapolis State:IN Country:United States Drugs Humalog Pharmaceutical Business Pharmaceutical Company Pharmaceuticals Therapy Treatment...
|
|
|
Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan
Aims: To compare hypoglycaemic events, glycated haemoglobin (HbA1c) and changes in body weight in Muslim patients with Type 2 diabetes receiving Humalog Mix 50 and human Mixtard 30 twice daily during Ramadan fasting.Methods: Data were collected from...
|
|
|
Insulin pump does the job well
Editor's note: This query from C.B.is the same one that appeared in Dr. Beach's February column, when he addressed the concept of basal bolus therapy (two insulins). Today, he responds to C.B.'s question about insulin pump therapy. Beach, A few of my...
|
|
|
After eight years on Humulin and Humalog, my son has been having a lot of lows. We reduced his insulin and he
My 10-year-old son loves to eat.He is right where he should be in height and weight. He is still taking Humulin as his long lasting insulin and Humalog for his short acting insulin and has been doing so for eight years. However, over the past week,...
|
|
|
How to get the most out of your insulin
CORPUS CHRISTI Insulin is the oldest drug for treating diabetes.But despite how long it has been available as a treatment, learning how to use it properly often is poorly understood by patients and doctors. Insulin is a protein. It works by attaching to...
|
|
|
Is my daughter's insulin regimen a cause for concern? Her breakfast ratio 1:1.6; lunch 1:2.3; and dinner 1:1.6
Now 18, my daughter weighs 130 pounds.She uses Humalog before meals and Lantus as her basal insulin. For breakfast, she takes 15 units of Humalog for 25 grams of carbohydrates. At lunch, when she eats 50 grams of carbohydrates, she takes 22...
|
|
|
Failings at Lilly Humalog plant catch FDA's eye
Eli Lilly has been sent a warning letter about a production facility in Puerto Rico, which says the company failed to adequately investigate problems with manufacturing the active pharmaceutical ingredient (API) used to make an insulin-based drug for diabetes....
|
|
|
FDA Issues Warning Letter To Eli Lilly For Irregularity At Puerto Rico API Facility
FDA has issued Eli Lilly with a warning letter detailing a significant deviation from cGMP at its API production facility in Puerto Rico, which makes ingredients used in Humalog (insulin lispro), a diabetes treatment.According to the warning letter,...
|
|
|
Lilly Cited for Quality Issues in P.R. Humalog Facility
The Agency cited Lilly for API testing and a failure to explain how it would res Lilly Cited for Quality Issues in P.R.Humalog Facility.
|
|
|
Lilly gets FDA warning on plant that makes Humalog ingredient
Eli Lilly and Co.received a warning letter from the FDA citing its lack of "sufficient corrective actions" on manufacturing violations at a Puerto Rican plant that produces the active ingredient in diabetes drug Humalog. Lilly gets FDA warning on...
|
|
|
Lillys Puerto Rico API plant issued with FDA warning letter
Related topics: Globalisation, Processing & QC, QA/QC & validation The FDA has issued Eli Lilly with a warning letter detailing a significant deviation from cGMP at its API production facility in Puerto Rico, which makes ingredients used in ...
|
|
|
US warns Lilly over insulin ingredient production
* FDA finds problem with insulin ingredient production * Agency asks for impact on Lilly's Humalog insulin * Lilly shares down 1 pct WASHINGTON, Feb 23 (Reuters) - U.S.health officials have warned Eli Lilly and Co about problems with the manufacturing...
|
|
|
UPDATE 2-US warns Lilly over insulin ingredient production
* FDA finds problem with insulin ingredient production * Agency asks for impact on Lilly's Humalog insulin * Lilly shares down 1 pct WASHINGTON, Feb 23 (Reuters) - U.S.health officials have warned Eli Lilly and Co <LLY.N> about problems with the...
|
|
|
UPDATE 1-US warns Lilly over insulin ingredient production
* FDA finds problem with insulin ingredient production * Agency asks for impact on Lilly's Humalog insulin * Lilly shares down 1 pct WASHINGTON, Feb 23 (Reuters) - U.S.health officials have warned Eli Lilly and Co <LLY.N> about problems with the...
|
|
|
FDA warns Eli Lilly over Puerto Rico plant
A July 2009 inspection of the Lilly plant in Carolina found problems with the production of an ingredient called Lyspro Insulin Zinc Crystals, the FDA said in a February 5 letter to the company posted on the federal agencys website Tuesday.The FDA said...
|
|
|
U.S. warns Lilly over insulin ingredient production
WASHINGTON (Reuters) - Health officials have warned Eli Lilly and Co about problems with the manufacturing of an insulin ingredient at a plant in Puerto Rico, a letter released on Tuesday said.A July 2009 inspection found problems with the production of an...
|
|
|
U.S. warns Lilly over insulin ingredient production
WASHINGTON (Reuters) - Health officials have warned Eli Lilly and Co about problems with the manufacturing of an insulin ingredient at a plant in Puerto Rico, a letter released on Tuesday said.A July 2009 inspection found problems with the production of an...
|
|
|
MannKind shares fall after insulin device delay
BOSTON (Reuters) - Shares of MannKind Corp <MNKD.O> fell as much as 7 percent on Monday after the company said U.S.regulators would delay a ruling on whether to approve the company's experimental inhaled insulin device. The company said late on...
|
